| CD102 | ICAM-2 (intercellular adhesion molecule-2) |
| Molecule Type | Antigen Expression | Molecular Weight Min / Max |
| Non-lineage Restricted Molecule Type 1 glycoprotein | Monocyte Platelet Dendritic Cell Endothelial Cell Lymphoma Cell Lymphocyte | 55 / 55 65 / 65 |
Expression | ||||||||||||||||||
| CD102 is expressed constitutively at high levels on vascular endothelial cells, on some resting lymphocytes, follicular dendritic cells on monocytes, on platelets but is not expressed on neutrophils. Expression is more restricted than CD54 and, unlike CD54, there is little or no induction of CD102 on lymphocytes and endothelial cells by inflammatory mediators. CD102 is induced in lymphomas. | ||||||||||||||||||
Structure | ||||||||||||||||||
| MOLECULAR FAMILY NAME: Belongs to the immunoglobulin supergene family. CD102 is a single-chain type-1 254 aa glycotprotein. It contained a 202 aa extracellular domain which contains 2 Ig-like C2-type domains, has 6 N-glycosyation sites and binds to the leukocyte adhesion LFA-1 protein, a 26 aa transmembrane domain and a 26 aa cytoplasmic domain. The 2 Ig domains share an ~36% sequence identity with the 2 membrane-distal IgSF domains of CD54 (ICAM-1) and CD50 (ICAM-3). CD102 is a member of the intracellular adhesion molecule (ICAM) family. MOLECULAR MASS
POST-TRANSCRIPTIONAL MODIFICATION: No information. POST-TRANSLATIONAL MODIFICATION There are 6 potential N-glycosylation sites in the extracellular domain. | ||||||||||||||||||
Ligands | ||||||||||||||||||
| CD102 is a ligand for the leukocyte integrin CD11a/CD18 (LFA-1), like the related proteins CD54 and CD50. CD102 has also been reported to bind CD11b/CD18 ( Mac-1). LIGANDS AND MOLECULES ASSOCIATED WITH CD102
| ||||||||||||||||||
Function | ||||||||||||||||||
| CD102 is an intracellular adhesion molecule and is believed to be involved in lymphocyte recirculation and homing to inflammatory sites. It also provides a costimulatory signal in the immune response through interaction with integrins. CD102 is the major CD11a LFA-1 ligand on endothelial cells that have not been activated by inflammatory stimuli suggesting a possible role in lymphocyte recirculation by LFA-1 dependent cell adhesion. It mediates adhesive interactions important for antigen-specific immune response, NK-cell mediated clearance, lymphocyte recirculation and other cellular interactions important for immune response and surveillance. Recombinant CD102 can also stimulate T cells in vitro suggesting a role in T cell activation and adhesion. BIOCHEMICAL ACTIVITY: No information. DISEASE RELEVANCE AND FUNCTION OF CD102 IN INTACT ANIMAL CD102 knockout mice show impaired recruitment of inflammatory cells and reduced numbers of bone marrow megakaryocyte precursors. CD102 is a potential pathology reagent because the CD102 levels are reportedly upregulated in lymph nodes with maignant infiltration. | ||||||||||||||||||
Comments | ||||||||||||||||||
MOLECULAR INTERACTIONS - | ||||||||||||||||||
Database accession numbers | ||||||||||||||||||
Revised June 25, 2008
|
||||||||||||||||||